e-learning
resources
Vienna 2012
Monday, 03.09.2012
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury
S.P. Arold, E.L. Berry, D. Rosa, F.A. Saia, S. Kong, P.L. Wright, R.W. Clarke, D.L. Hava (Lexington, United States Of America)
Source:
Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session:
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session type:
Thematic Poster Session
Number:
2128
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S.P. Arold, E.L. Berry, D. Rosa, F.A. Saia, S. Kong, P.L. Wright, R.W. Clarke, D.L. Hava (Lexington, United States Of America). Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury. Eur Respir J 2012; 40: Suppl. 56, 2128
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Inhaled calcium salts reduce expression of inflammatory mediators associated with tobacco smoke exposure to reduce airway inflammation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Modulation of chronic airway inflammation in guinea pigs by oral tolerance: effects in lung mechanics, cellular infiltration and nitric oxide production
Source: Eur Respir J 2002; 20: Suppl. 38, 382s
Year: 2002
Dexamethasone reduces lung inflammation induced by alveolar stretch in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Impaired lung function is associated with systemic inflammation and macrophage activation
Source: Eur Respir J 2015; 45: 557-559
Year: 2015
Effect of curcumin on LPS-induced neutrophil activation and acute lung injury
Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation
Year: 2012
Chronic nitric oxide inhibition modulates inflammatory cells apoptosis induced by dexamethasone in guinea pigs with chronic airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005
Inhaled CCR1 antagonist AZD4818 reduces leucocyte influx in the rat lipopolysaccharide (LPS) lung inflammation model
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009
CD101 eosinophil serves as an early response to suppress endotoxin-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004
Anethole improves lipopolysaccharide (LPS)-induced lung injury
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Inhaled nitric oxide increases alveolar liquid clearance in rabbit with endotoxin induced lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004
Inhaled activated protein C protects mice from ventilator-induced lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
iNOS inhibition reduces lung vascular inflammation and remodelling induced by repeated particulate matter instillation
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Adrenaline stimulated mesenchymal stem cells modulate inflammation in lipopolysaccharide induced lung injury
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
Inhaled insulin does not trigger lung inflammation and airway remodelling
Source: Eur Respir J 2009; 33: 444-445
Year: 2009
Soluble biglycan promotes ovalbumin induced airway inflammation by modulating dendritic cell function in mice
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 375s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept